EDIT-ART
FUNDAMENTAL ISSUES IN CIRCULATORY SYSTEM DISEASES
Purpose. To reveal the association of polymorphisms within the genes encoding Toll-like receptors (TLRs) with carbohydrate metabolism disorders (CMDs) in patients with coronary artery disease (CAD).
Materials and methods. Study sample included 292 patients with coronary artery disease. We investigated 8 polymorphisms within 4 genes: TLR1 (rs5743551 and rs5743611), TLR2 (rs3804099 and rs5743708), TLR4 (rs4986790 and rs4986791), TLR6 (rs3775073 and rs5743810).
Results. T allele of the rs4986791 (Thr399Ile) polymorphism and G allele of rs4986790 (Asp299Gly) polymorphism within TLR4 gene are significantly associated with decreased risk of CMDs, whereas G allele of rs5743611 polymorphism within TLR1 gene is significantly associated with higher risk of CMDs.
Conclusion. We found significant associations of the polymorphisms within the genes encoding TLRs (T allele of rs4986791 polymorphism and G allele of rs4986790 polymorphism within TLR4 gene and G allele of rs5743611 polymorphism within TLR1 gene) with CMDs in patients with CAD.
EPIDEMIOLOGY OF DISEASES OF THE CIRCULATORY
Purpose. To analyze the long-term survival of patients with myocardial infarction (MI), according to its type (primary or recurrent MI), age and gender.
Materials and methods. 791 patients with MI admitted to the Kemerovo Cardiology Dispensary in 2006 were included in the study. The follow-up period was 8,5 years. The Kaplan-Meier analysis was performed to estimate the survival rates. A p value of 0,05 is considered statistically significant. The odds ratio (OR) with the 95 % confidence interval was calculated.
Results. A total of 791 patients, 565 (71,4 %) of whom were present with primary and 226 (28,6 %) with recurrent MI were included in the study. Overall, 446 (56,3 %) patients died during the follow-up period. The cause of death was known in 365 patients (81,8 %). The major cause of death was circulatory system diseases (88,2 %). The survival rate for seven years in patients with primary MI was 49,8 % and in patients with recurrent MI – 31,5 % (p=0,00001, OR=2,2 [1,5, 3,0]). The risk of death was greatest in the first year after any type of MI; however, the risk of death after recurrent MI increased 2-fold, compared with primary MI. The long-term survival was lower in females than in males (p=0,0065, OR=1,42 [1,07; 1,90]). In case of primary IM, this parameter was also worse in females than in males (p=0,002, OR=1,6 [1,1; 2,2]). However, there were no gender-related differences in the long-term survival after recurrent MI (p=0,33, OR=1,1 [0,6; 1,9]).
Conclusion. The results of the present study suggest a higher risk of death and poor long-term survival in patients with recurrent myocardial infarction compared to patients with primary MI.
RELEVANT COMORBID PATHOLOGY
ANALYTICAL REVIEWS
Purpose. To study the endothelial function in the onset of arterial hypertension (AH) in perimenopausal women and to evaluate the possibility of the influence of antihypertensive therapy on endothelial dysfunction.
Materials and methods. The study included 81 patients with essential hypertension (EH) I–II stage of 1–2 degrees and 23 healthy perimenopausal women. The level of estradiol and follicle stimulating hormone (FSH) were analyzed. Endothelial function was assessed by endothelium-dependent (EDVD), endothelium-independent (ENVD) vasodilation of the brachial artery and laboratory markers.
Results. Regardless of the AH stage and degree 50 % of patients had endothelial dysfunction by EDVD / ENVD and vasoconstriction endothelial markers (endothelin-1 (ET-1), asymmetric dimethylarginine (ADMA)) were increased. 12 weeks of treatment showed a statically significant reduction (p<0,05) in the concentration of ET-1 and ADMA, and increasing NO production (p<0,05) in all patients with hypertension.
Conclusion. Perimenopausal women with EH regardless of the stage and degree blood pressure had a violation of EDVD/ ENVD and a change of endothelial markers. Monotherapy blockers of the renin-angiotensin-aldosterone system (RAAS) showed blood pressure normalisation and endothelial function improvement in most women with AH stage I-II and 1 degree, with 2 degree required a combination therapy with the addition of bisoprolol and low doses of hydrochlorothiazide to RAAS.
CASE STUDY
ISSN 2587-9537 (Online)